Literature DB >> 6812036

Early onset life-threatening myelosuppression after low dose of intravesical thiotepa.

G Agnelli, M de Cunto, P Gresele, A del Favero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6812036      PMCID： PMC2426344          DOI： 10.1136/pgmj.58.680.380

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  Intravesical chemotherapy and chemoprevention of superficial, low grade, low stage bladder carcinoma.

Authors:  W W Koontz
Journal:  Semin Oncol       Date:  1979-06       Impact factor: 4.929

2.  Thiotepa in the treatment of tumours of the bladder.

Authors:  H C JONES; J SWINNEY
Journal:  Lancet       Date:  1961-09-16       Impact factor: 79.321

3.  The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers.

Authors:  J E Drew; V F Marshall
Journal:  J Urol       Date:  1968-06       Impact factor: 7.450

4.  Pancytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide.

Authors:  D Bruce; J H Edgcomb
Journal:  J Urol       Date:  1967-03       Impact factor: 7.450

5.  Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder.

Authors:  A Abbassian; D M Wallace
Journal:  J Urol       Date:  1966-10       Impact factor: 7.450

6.  The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.

Authors:  J W Wescott
Journal:  J Urol       Date:  1966-12       Impact factor: 7.450

7.  Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.

Authors:  R J Veenema; A L Dean; A C Uson; M Roberts; F Longo
Journal:  J Urol       Date:  1969-05       Impact factor: 7.450

8.  The use of chemotherapeutic agents in the prophylaxis of papillary bladder tumours.

Authors:  M Pavone-Macaluso; G Caramia; F P Rizzo
Journal:  Urol Int       Date:  1971       Impact factor: 2.089

9.  [Effects of intravesical instillation of antitumor agents on bladder cancer].

Authors:  T Tomiyama
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1972-07

10.  Hematologic effects of intravesicular thiotepa therapy for bladder carcinoma.

Authors:  D Hollister; M Coleman
Journal:  JAMA       Date:  1980-11-07       Impact factor: 56.272
  10 in total
  1 in total

1.  Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects.

Authors:  B Hagen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.